Researcher.Life Logo

Metabolic Brain Disease : Impact Factor & More

eISSN: 1573-7365pISSN: 0885-7490

Key Metrics

CiteScore
5.8
Eigenfactor
0.005 - 0.01
Impact Factor
< 5
SJR
Q2Biochemistry
SNIP
1.02
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Metabolic Brain Disease

Metabolic Brain Disease Journal Specifications

Overview
Publisher SPRINGER/PLENUM PUBLISHERS
Language English
Frequency Bi-monthly
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year1986
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Metabolic Brain Disease ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Metabolic Brain Disease

Genistein-3'-sodium sulfonate improves neuroinflammation, blood-brain barrier function, and microglial activation after chronic cerebral hypoperfusion by regulating TGR5.
  • 20 May 2026
  • Metabolic brain disease
Neuroprotective effects of myrtenol against brain injury following isoproterenol-induced myocardial infarction in male rats.
  • 20 May 2026
  • Metabolic brain disease
Mild hypothermia inhibits the inflammatory response and microglial M1 polarization in ischemic stroke via the EFNB2/EphB4 pathway.
  • 20 May 2026
  • Metabolic brain disease
Neuroprotective effects of trans-anethole on AlCl₃-induced memory impairment: targeting AChE, oxidative stress, and NLRP3 inflammasome: a promising approach for neurodegeneration prevention.
  • 19 May 2026
  • Metabolic brain disease
Impact of prenatal LPS on sepsis-related neurobiological outcomes.
  • 19 May 2026
  • Metabolic brain disease
Plant-derived neuroprotective compounds and nanoformulations targeting Parkinson's disease: a semi-systematic review of mechanisms and therapeutic potential.
  • 19 May 2026
  • Metabolic brain disease
Genistein-3'-sodium sulfonate improves neuroinflammation, blood-brain barrier function, and microglial activation after chronic cerebral hypoperfusion by regulating TGR5.
  • 20 May 2026
  • Metabolic brain disease
Neuroprotective effects of myrtenol against brain injury following isoproterenol-induced myocardial infarction in male rats.
  • 20 May 2026
  • Metabolic brain disease
Mild hypothermia inhibits the inflammatory response and microglial M1 polarization in ischemic stroke via the EFNB2/EphB4 pathway.
  • 20 May 2026
  • Metabolic brain disease
Neuroprotective effects of trans-anethole on AlCl₃-induced memory impairment: targeting AChE, oxidative stress, and NLRP3 inflammasome: a promising approach for neurodegeneration prevention.
  • 19 May 2026
  • Metabolic brain disease
Impact of prenatal LPS on sepsis-related neurobiological outcomes.
  • 19 May 2026
  • Metabolic brain disease
Plant-derived neuroprotective compounds and nanoformulations targeting Parkinson's disease: a semi-systematic review of mechanisms and therapeutic potential.
  • 19 May 2026
  • Metabolic brain disease

FAQs on Metabolic Brain Disease